PHARMULA
Balance sheet
balance sheet total €126,721 on 31-12-2025in euro
in euro
Position in the sector
15.1%
Higher than 24% of 10,278 companies in 2025.
1.15
Higher than 33% of 9,860 companies in 2025.
32.9%
Higher than 78% of 10,002 companies in 2025.
Net result: middle half · Equity: middle half · Balance sheet total: middle half · Working capital: middle half
Filed annual accounts
as filed with the National Bank, click a year to choose it| Line | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Balance sheet: assets | |||||
20/58 |
126,721 | 136,527 | 104,783 | 81,886 | |
21/28 |
3,049 | 1,142 | 1,843 | 2,162 | |
22/27 |
3,049 | 1,142 | 1,843 | 2,162 | |
24 |
441 | 1,142 | 1,843 | 2,162 | |
26 |
2,609 | - | - | - | |
29/58 |
123,671 | 135,385 | 102,941 | 79,724 | |
40/41 |
20,344 | 33,636 | 39,489 | 14,932 | |
40 |
20,184 | 10,558 | 15,674 | 14,932 | |
41 |
160 | 23,078 | 23,815 | 0 | |
54/58 |
103,093 | 101,749 | 63,451 | 59,040 | |
490/1 |
235 | - | 0 | 5,753 | |
| Balance sheet: equity and liabilities | |||||
10/49 |
126,721 | 136,527 | 104,783 | 81,886 | |
10/15 |
19,139 | 126,667 | 84,657 | 49,127 | |
10/11 |
2,400 | 2,400 | 2,400 | 2,400 | |
14 |
16,739 | 124,267 | 82,257 | 46,727 | |
17/49 |
107,582 | 9,859 | 20,127 | 32,759 | |
42/48 |
107,582 | 9,859 | 20,127 | 32,759 | |
44 |
468 | 1,058 | 889 | 1,142 | |
440/4 |
468 | 1,058 | 889 | 1,142 | |
45 |
4,635 | 8,801 | 19,238 | 23,170 | |
450/3 |
4,635 | 8,801 | 19,238 | 23,170 | |
454/9 |
- | 0 | 0 | 0 | |
47/48 |
102,478 | 0 | 0 | 8,446 | |
| Income statement | |||||
70 |
- | 0 | 0 | 0 | |
9900 |
58,361 | 58,312 | 49,001 | 60,298 | |
60/61 |
- | 0 | 0 | 0 | |
630 |
875 | 701 | 261 | 838 | |
640/8 |
400 | - | 856 | 281 | |
66A |
- | 1,209 | - | - | |
9901 |
57,086 | 56,402 | 47,885 | 59,178 | |
75/76B |
- | 1,421 | 632 | 6 | |
75 |
- | 1,421 | 632 | 6 | |
65/66B |
507 | 498 | 398 | 67 | |
65 |
507 | 498 | 398 | 67 | |
9903 |
56,579 | 57,325 | 48,119 | 59,117 | |
67/77 |
14,840 | 15,315 | 12,590 | 12,390 | |
9904 |
41,739 | 42,011 | 35,529 | 46,727 | |
9905 |
41,739 | 42,011 | 35,529 | 46,727 | |
| Appropriation of the result | |||||
9906 |
166,007 | 124,267 | 82,257 | 46,727 | |
14P |
124,267 | 82,257 | 46,727 | - | |
694/7 |
149,267 | - | - | - | |
694 |
149,267 | - | - | - | |
| Document | |||||
The notes to these accounts have 5 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.
Source: Annual accounts 2025 at the NBB, filed on 22-06-2026.
Filings
each dot is a set of accounts, on the day it reached the National BankKey figures and ratios
per financial year, computed from the annual accounts| Line | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| 57,961 | 57,103 | 48,145 | 60,016 | ||
| 42,614 | 42,712 | 35,790 | 47,566 | ||
| 2,782 | 0 | 2,103 | 3,000 | ||
| 1,344 | 38,298 | 4,411 | - | ||
| 16,090 | 125,526 | 82,814 | 46,966 | ||
| 15.1% | 92.8% | 80.8% | 60.0% | ||
| 1.15 | 13.73 | 5.11 | 2.43 | ||
| 5.62 | 0.08 | 0.24 | 0.67 | ||
| 218.1% | 33.2% | 42.0% | 95.1% | ||
| 32.9% | 30.8% | 33.9% | 57.1% | ||
| over 100 | over 100 | over 100 | over 100 |
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
Investments
fixed assets acquired| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Tangible fixed assets | €2,782 | €0 | €2,103 | €3,000 |
| €875 | €701 | €261 | €838 |
Source: notes to the 2022 to 2025 annual accounts (statement of fixed assets)
Insights on PHARMULA
The operating result for 2025 is 1% higher than in 2024 and the highest since 2022. It is the second rise in a row, after the fall in 2023.
Debt's share of the balance-sheet total rises from 7.2% to 84.9%. Equity is lower and debt is higher.